| abstract |
Disclosed is a compound of general formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein C is a chelating agent unit; AB is an albumin binding unit; and FAPI is a fibroblast activated protein inhibitor unit. Further disclosed are a chelate of the above-mentioned compound and a radionuclide, a pharmaceutical composition, and the use thereof as a fibroblast activated protein inhibitor in the diagnosis and treatment of diseases. C-AB-FAPI (I) |